Uninsured Americans pay high costs for an insulin Eli Lilly vowed to price at $25, Sen. Warren says
Publishing timestamp: 2023-07-13 20:27:13
Summary
The article discusses a report released by Sen. Elizabeth Warren, which reveals that uninsured Americans are still paying nearly $98 on average for a vial of Eli Lilly's generic insulin, despite the company's promise to slash the list price to $25 per vial. The report calls for Congress to take additional steps to reduce the excessive prices of insulin from Eli Lilly and other manufacturers. It also highlights the challenges faced by uninsured individuals in accessing affordable insulin and the need for action to ensure access to life-saving medication.
Sentiment: NEGATIVE
Tickers: SAN-FR, LLY, NOVO.B-DK,
Keywords: sanofi sa, social issues, business, elizabeth warren, diabetes, pharmaceuticals, health care industry, biotech and pharmaceuticals, business news, biotechnology, politics, breaking news: politics, eli lilly and co, breaking news, novo nordisk a/s,